Lactobacillus plantarum CUL66 can impact cholesterol homeostasis in Caco-2 enterocytes [PDF]
Hypercholesterolemia drives the development of cardiovascular disease, the leading cause of mortality in western society. Supplementation with probiotics that interfere with cholesterol metabolism may provide a contribution to disease prevention ...
Calvente, D. Lama +5 more
core +1 more source
Hepatic NPC1L1 overexpression attenuates alcoholic autophagy in mice
Alcohol consumption causes liver steatosis in humans. Metabolic disorders of lipids are one of the factors that cause liver steatosis in hepatocytes. Hepatic Niemann‑Pick C1‑like 1 (NPC1L1) regulates lipid homeostasis in mammals. The relationship between NPC1L1 and autophagy in those with a history of alcohol abuse is unclear.
Wang, Youlin +7 more
openaire +3 more sources
Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats. [PDF]
Niemann-Pick C1-Like 1 (NPC1L1) mediates cholesterol absorption, and ezetimibe is a potent NPC1L1 inhibitor applicable for medication of hypercholesterolemia.
Mari Nekohashi +7 more
doaj +1 more source
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
Elevated cholesterol significantly increases the risk of developing atherosclerosis and coronary heart disease. The key to treating hypercholesterolemia is lowering plasma cholesterol levels.
Wenjing Liu +16 more
doaj +1 more source
Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation [PDF]
Prolonged ingestion of a cholesterol- or saturated fatty acid-enriched diet induces chronic, often systemic, auto-inflammatory responses resulting in significant health problems worldwide.
Bugeon, L +10 more
core +3 more sources
Mathematically modelling the dynamics of cholesterol metabolism and ageing [PDF]
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the UK. This conditionbecomes increasingly prevalent during ageing; 34.1% and 29.8% of males and females respectively, over 75years of age have an underlying cardiovascular ...
A.E. Morgan +116 more
core +3 more sources
SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin [PDF]
Curcumin, the major phenolic compound in the spice turmeric, exhibits numerous biological effects, including lowering plasma cholesterol and preventing diet-induced hypercholesterolemia. The mechanisms underlying the hypocholesterolemic effect of curcumin are not fully understood.
Pradeep, Kumar +8 more
openaire +2 more sources
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. [PDF]
Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.
Agnello +88 more
core +7 more sources
Genetic Variation in NPC1L1 and Risk of Gallstone Disease
We read with great interest the recent paper by Ference et al. [(1)][1] using genetic variants in NPC1L1 (target for ezetimibe) and HMGCR (target for statins) to predict the effect of ezetimibe and statins on low-density lipoprotein (LDL) cholesterol and risk of coronary heart disease ...
Lauridsen, Bo Kobberø +2 more
openaire +3 more sources
Novel polyketide from Fusarium verticillioide G102 as NPC1L1 inhibitors
One novel polyketide, fusaritide A (1), was isolated from a marine fish-derived halotolerant fungal strain Fusarium verticillioide G102. The structure was determined through extensive spectroscopic analysis and high-resolution electrospray ionization mass spectrometry.
Yuhan Zhang +9 more
openaire +2 more sources

